TY - JOUR
T1 - Homozygous MED25 mutation implicated in eye–intellectual disability syndrome
AU - Basel-Vanagaite, Lina
AU - Smirin-Yosef, Pola
AU - Essakow, Jenna Lee
AU - Tzur, Shay
AU - Lagovsky, Irina
AU - Maya, Idit
AU - Pasmanik-Chor, Metsada
AU - Yeheskel, Adva
AU - Konen, Osnat
AU - Orenstein, Naama
AU - Weisz Hubshman, Monika
AU - Drasinover, Valerie
AU - Magal, Nurit
AU - Peretz Amit, Gaby
AU - Zalzstein, Yael
AU - Zeharia, Avraham
AU - Shohat, Mordechai
AU - Straussberg, Rachel
AU - Monté, Didier
AU - Salmon-Divon, Mali
AU - Behar, Doron M.
N1 - Publisher Copyright:
© 2015, Springer-Verlag Berlin Heidelberg.
PY - 2015/6/1
Y1 - 2015/6/1
N2 - Genetic syndromes involving both brain and eye abnormalities are numerous and include syndromes such as Warburg micro syndrome, Kaufman oculocerebrofacial syndrome, Cerebro-oculo-facio-skeletal syndrome, Kahrizi syndrome and others. Using exome sequencing, we have been able to identify homozygous mutation p.(Tyr39Cys) in MED25 as the cause of a syndrome characterized by eye, brain, cardiac and palatal abnormalities as well as growth retardation, microcephaly and severe intellectual disability in seven patients from four unrelated families, all originating from the same village. The protein encoded by MED25 belongs to Mediator complex or MED complex, which is an evolutionary conserved multi-subunit RNA polymerase II transcriptional regulator complex. The MED25 point mutation is located in the von Willebrand factor type A (MED25 VWA) domain which is responsible for MED25 recruitment into the Mediator complex; co-immunoprecipitation experiment demonstrated that this mutation dramatically impairs MED25 interaction with the Mediator complex in mammalian cells.
AB - Genetic syndromes involving both brain and eye abnormalities are numerous and include syndromes such as Warburg micro syndrome, Kaufman oculocerebrofacial syndrome, Cerebro-oculo-facio-skeletal syndrome, Kahrizi syndrome and others. Using exome sequencing, we have been able to identify homozygous mutation p.(Tyr39Cys) in MED25 as the cause of a syndrome characterized by eye, brain, cardiac and palatal abnormalities as well as growth retardation, microcephaly and severe intellectual disability in seven patients from four unrelated families, all originating from the same village. The protein encoded by MED25 belongs to Mediator complex or MED complex, which is an evolutionary conserved multi-subunit RNA polymerase II transcriptional regulator complex. The MED25 point mutation is located in the von Willebrand factor type A (MED25 VWA) domain which is responsible for MED25 recruitment into the Mediator complex; co-immunoprecipitation experiment demonstrated that this mutation dramatically impairs MED25 interaction with the Mediator complex in mammalian cells.
UR - http://www.scopus.com/inward/record.url?scp=84936777719&partnerID=8YFLogxK
U2 - 10.1007/s00439-015-1541-x
DO - 10.1007/s00439-015-1541-x
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:84936777719
SN - 0340-6717
VL - 134
SP - 577
EP - 587
JO - Human Genetics
JF - Human Genetics
IS - 6
ER -